- ¥4tn
- ¥4tn
- ¥922bn
- 97
- 20
- 96
- 87
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 28.93 | ||
PEG Ratio (f) | 2.01 | ||
EPS Growth (f) | 16.85% | ||
Dividend Yield (f) | 1.03% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.81 | ||
Price to Tang. Book | 4.97 | ||
Price to Free Cashflow | 43.24 | ||
Price to Sales | 4.13 | ||
EV to EBITDA | 16.95 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 9.51% | ||
Return on Equity | 8.98% | ||
Operating Margin | 16.07% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | ¥m | 628,897 | 613,842 | 703,303 | 820,209 | 921,863 | 1,015,129 | 1,080,301 | 8.99% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +13.61 | -8.47 | +16.79 | +2.86 | +20.12 | +19.67 | +13.92 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
TERUMO CORPORATION is a manufacturer of medical supplies. The Company operates in three segments. The Cardiac and Vascular Company segment is engaged in the manufacture of catheter system and cardiopulmonary system products, the import of the cardiopulmonary systems and artificial blood vessels, as well as the sale of products mainly to hospitals and clinics nationwide through agents. The Hospital Company segment is engaged in the manufacture, purchase and sale of hospital medical equipment, pharmaceuticals, peritoneal dialysis and diabetes related products, and the rental of hospital medical equipment and home medical products. The segment is also engaged in the manufacture and sale of healthcare related products. The Blood System Company segment is engaged in the manufacture and sale of blood transfusion-related products.
Directors
- Takayoshi Mimura CHM (67)
- Shinjiro Sato PRE (61)
- Naoki Muto CFO (58)
- Kyo Nishikawa CHO (62)
- Fumihisa Hirose CTO
- Katsuya Takeuchi CIO
- Toshiaki Takagi SME (63)
- Shoji Hatano MEO (62)
- Toshihiko Osada MEO
- Hikaru Samejima MEO (57)
- Kazunori Hirose SEO
- Tetsuya Kumei SEO
- Itaru Sakaguchi SEO
- Tsuyoshi Tomita SEO
- Nishizaki Hitoshi DSL
- Kenichi Ikeda DSL
- Keiji Takeda DHR
- Probir Das EXO
- Robato Deraiku EXO
- Robert DeRyke EXO
- Antoinette Gawin EXO
- Kazunobu Handa EXO
- Yagi Hiroshi EXO
- Paul Holbrook EXO
- Masanori Hoshino EXO
- Norimasa Kunimoto EXO (58)
- Takeshi Kuroo EXO
- Tomoko Manabe EXO
- Masayuki Maruta EXO
- Miho Mizuguchi EXO
- Hiroshi Nagumo EXO
- Toshio Nakashima EXO
- James Rushworth EXO
- Kazuhisa Senshu EXO
- Takanori Shibazaki DRC (59)
- Yukiko Kuroda IND (57)
- Masaichi Nakamura IND (64)
- Hidenori Nishi IND (70)
- Soichiro Uno IND (58)
- Last Annual
- March 31st, 2024
- Last Interim
- June 30th, 2024
- Incorporated
- September 17th, 1921
- Public Since
- June 21st, 1982
- No. of Shareholders
- 45,195
- No. of Employees
- 30,591
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 1,484,855,220
- Address
- 2-44-1, Hatagaya, SHIBUYA-KU, 151-0072
- Web
- https://www.terumo.co.jp/
- Phone
- +81 333748111
- Auditors
- KPMG AZSA LLC
Upcoming Events for 4543
Q2 2025 Terumo Corp Earnings Release
Q3 2025 Terumo Corp Earnings Release
Similar to 4543
Alfresa Holdings
Tokyo Stock Exchange
Asahi Intecc Co
Tokyo Stock Exchange
Aso International
Tokyo Stock Exchange
As One
Tokyo Stock Exchange
Atect
Tokyo Stock Exchange
FAQ
As of Today at 23:39 UTC, shares in Terumo are trading at ¥2,683. This share price information is delayed by 15 minutes.
Shares in Terumo last closed at ¥2,683 and the price had moved by +25.76% over the past 365 days. In terms of relative price strength the Terumo share price has outperformed the Nikkei 225 Index by +12.74% over the past year.
The overall consensus recommendation for Terumo is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Terumo dividend yield is 0.82% based on the trailing twelve month period.
Last year, Terumo paid a total dividend of ¥22, and it currently has a trailing dividend yield of 0.82%.Looking ahead, shares in Terumo are due to go ex-dividend on 2024-09-27 and the next dividend pay date is 2024-12-01.
Terumo are due to go ex-dividend on 2024-09-27 and the next dividend pay date is 2024-12-01. The historic dividend yield on Terumo shares is currently 0.82%.
To buy shares in Terumo you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of ¥2,683, shares in Terumo had a market capitalisation of ¥4tn.
Here are the trading details for Terumo:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 4543
Based on an overall assessment of its quality, value and momentum Terumo is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Terumo is ¥3,212. That is 19.7% above the last closing price of ¥2,683.
Analysts covering Terumo currently have a consensus Earnings Per Share (EPS) forecast of ¥87 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Terumo. Over the past six months, its share price has outperformed the Nikkei 225 Index by +0.94%.
As of the last closing price of ¥2,683, shares in Terumo were trading +2.24% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Terumo PE ratio based on its reported earnings over the past 12 months is 28.93. The shares last closed at ¥2,683.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Terumo's management team is headed by:
- Takayoshi Mimura - CHM
- Shinjiro Sato - PRE
- Naoki Muto - CFO
- Kyo Nishikawa - CHO
- Fumihisa Hirose - CTO
- Katsuya Takeuchi - CIO
- Toshiaki Takagi - SME
- Shoji Hatano - MEO
- Toshihiko Osada - MEO
- Hikaru Samejima - MEO
- Kazunori Hirose - SEO
- Tetsuya Kumei - SEO
- Itaru Sakaguchi - SEO
- Tsuyoshi Tomita - SEO
- Nishizaki Hitoshi - DSL
- Kenichi Ikeda - DSL
- Keiji Takeda - DHR
- Probir Das - EXO
- Robato Deraiku - EXO
- Robert DeRyke - EXO
- Antoinette Gawin - EXO
- Kazunobu Handa - EXO
- Yagi Hiroshi - EXO
- Paul Holbrook - EXO
- Masanori Hoshino - EXO
- Norimasa Kunimoto - EXO
- Takeshi Kuroo - EXO
- Tomoko Manabe - EXO
- Masayuki Maruta - EXO
- Miho Mizuguchi - EXO
- Hiroshi Nagumo - EXO
- Toshio Nakashima - EXO
- James Rushworth - EXO
- Kazuhisa Senshu - EXO
- Takanori Shibazaki - DRC
- Yukiko Kuroda - IND
- Masaichi Nakamura - IND
- Hidenori Nishi - IND
- Soichiro Uno - IND